# OnCo record domenica-lorusso (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/domenica-lorusso/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "domenica-lorusso" ;
  schema:name "Domenica Lorusso"@en ;
  schema:description "Led KEYNOTE-A18, which showed adding pembrolizumab to chemoradiotherapy improves survival in locally advanced cervical cancer."@en ;
  schema:url <https://onco.cc/people/domenica-lorusso/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Lorusso%20D%5BAuthor%5D%20cervical%20pembrolizumab> ;
  onco:tag "cervical", "immunotherapy", "italy" ;
  schema:jobTitle "Director of Gynaecological Oncology, Humanitas San Pio X and Humanitas University, Milan" ;
  schema:sameAs <https://orcid.org/0000-0003-0981-0598> ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/humanitas/> ;
  onco:trials <https://onco.cc/trials/keynote-a18/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-a18-pfs-lancet-2024/>, <https://onco.cc/key-papers/paper-keynote-a18-os-lancet-2024/> ;
  schema:affiliation <https://onco.cc/institutions/humanitas/> .